174 related articles for article (PubMed ID: 8499625)
1. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura.
Fujisawa K; Tani P; Piro L; McMillan R
Blood; 1993 Jun; 81(11):2872-7. PubMed ID: 8499625
[TBL] [Abstract][Full Text] [Related]
2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
3. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
[TBL] [Abstract][Full Text] [Related]
4. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
5. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
6. Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
Fabrizio F; Luzzatto G; Ramon R; Randi ML; De Silvestro G; Girolami A
Haematologica; 2000 Aug; 85(8):888-90. PubMed ID: 10942951
[No Abstract] [Full Text] [Related]
7. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
8. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
Saulsbury FT; Bringelsen KA
Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
[TBL] [Abstract][Full Text] [Related]
9. Danazol for the treatment of idiopathic thrombocytopenic purpura.
Ahn YS; Harrington WJ; Simon SR; Mylvaganam R; Pall LM; So AG
N Engl J Med; 1983 Jun; 308(23):1396-9. PubMed ID: 6682484
[TBL] [Abstract][Full Text] [Related]
10. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
Sikorska A; Konopka L; Maślanka K
Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
[TBL] [Abstract][Full Text] [Related]
11. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
12. Management of adult idiopathic thrombocytopenic purpura.
Cines DB; McMillan R
Annu Rev Med; 2005; 56():425-42. PubMed ID: 15660520
[TBL] [Abstract][Full Text] [Related]
13. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
14. Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids.
Kotlarek-Haus S; Podolak-Dawidziak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):768-76. PubMed ID: 2453406
[TBL] [Abstract][Full Text] [Related]
15. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology and treatment of idiopathic thrombocytopenic purpura].
Dan K
Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):319-26. PubMed ID: 8937118
[No Abstract] [Full Text] [Related]
17. Idiopathic thrombocytopenic purpura.
Burns TR; Saleem A
Am J Med; 1983 Dec; 75(6):1001-7. PubMed ID: 6685977
[TBL] [Abstract][Full Text] [Related]
18. [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].
Böcher A; Hagmann FG; Kreiter H
Med Klin (Munich); 1998 Dec; 93(12):707-18. PubMed ID: 10024838
[TBL] [Abstract][Full Text] [Related]
19. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of platelet recovery in ITP associated with therapy.
Pang SJ; Lazarus AH
Ann Hematol; 2010 Jul; 89 Suppl 1():31-5. PubMed ID: 20179926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
